Patents by Inventor Hao-Yeh Lin

Hao-Yeh Lin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11781124
    Abstract: Disclosed herein are recombinant polynucleotide sequences, vectors, host cells and methods for producing astaxanthin. The recombinant polynucleotide sequence is designed to provide a higher level of astaxanthin precursors via a shorter metabolic pathway, and thereby attains higher level of end products (e.g., astaxanthin) with desired stereoisomeric form and/or esterified form.
    Type: Grant
    Filed: November 10, 2020
    Date of Patent: October 10, 2023
    Assignee: ACADEMIA SINICA
    Inventors: Jui-Jen Chang, Caroline Thia, Hao-Yeh Lin, Yu-Ju Lin, Chieh-Chen Huang, Wen-Hsiung Li
  • Publication number: 20210071153
    Abstract: Disclosed herein are recombinant polynucleotide sequences, vectors, host cells and methods for producing astaxanthin. The recombinant polynucleotide sequence is designed to provide a higher level of astaxanthin precursors via a shorter metabolic pathway, and thereby attains higher level of end products (e.g., astaxanthin) with desired stereoisomeric form and/or esterified form.
    Type: Application
    Filed: November 10, 2020
    Publication date: March 11, 2021
    Inventors: Jui-Jen CHANG, CAROLINE THIA, HAO-YEH LIN, YU-JU LIN, CHIEH-CHEN HUANG, WEN-HSIUNG LI
  • Patent number: 10865397
    Abstract: Disclosed herein are recombinant polynucleotide sequences, vectors, host cells and methods for producing astaxanthin. The recombinant polynucleotide sequence is designed to provide a higher level of astaxanthin precursors via a shorter metabolic pathway, and thereby attains higher level of end products (e.g., astaxanthin) with desired stereoisomeric form and/or esterified form.
    Type: Grant
    Filed: November 26, 2018
    Date of Patent: December 15, 2020
    Assignee: ACADEMIA SINICA
    Inventors: Jui-Jen Chang, Caroline Thia, Hao-Yeh Lin, Yu-Ju Lin, Chieh-Chen Huang, Wen-Hsiung Li
  • Publication number: 20190144841
    Abstract: Disclosed herein are recombinant polynucleotide sequences, vectors, host cells and methods for producing astaxanthin. The recombinant polynucleotide sequence is designed to provide a higher level of astaxanthin precursors via a shorter metabolic pathway, and thereby attains higher level of end products (e.g., astaxanthin) with desired stereoisomeric form and/or esterified form.
    Type: Application
    Filed: November 26, 2018
    Publication date: May 16, 2019
    Inventors: Jui-Jen CHANG, Caroline THIA, Hao-Yeh LIN, Yu-Ju LIN, Chieh-Chen HUANG, Wen-Hsiung LI
  • Patent number: 10087450
    Abstract: Described herein is an engineered Kluyveromyces marxianus cell, the cell comprising in its genome: (i) two different nucleic acid molecules that each contain a promoter operably linked to a gene encoding a functional enzyme, and (ii) a selection nucleic acid molecule that contains a promoter operably linked to a gene encoding a selectable marker, wherein all of the nucleic acids molecules of (i) and (ii) are in tandem and the engineered cell expresses all of the proteins encoded by the genes of (i) and (ii).
    Type: Grant
    Filed: May 17, 2016
    Date of Patent: October 2, 2018
    Assignee: Academia Sinica
    Inventors: Jui-Jen Chang, Wen-Hsiung Li, Chieh-Chen Huang, Hao-Yeh Lin, Ming-Che Shih
  • Publication number: 20170137792
    Abstract: Disclosed herein are recombinant polynucleotide sequences, vectors, host cells and methods for producing astaxanthin. The recombinant polynucleotide sequence is designed to provide a higher level of astaxanthin precursors via a shorter metabolic pathway, and thereby attains higher level of end products (e.g., astaxanthin) with desired stereoisomeric form and/or esterified form.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 18, 2017
    Inventors: Jui-Jen CHANG, Caroline THIA, Hao-Yeh LIN, Yu-Ju LIN, Chieh-Chen HUANG, Wen-Hsiung LI
  • Publication number: 20160251663
    Abstract: Described herein is an engineered Kluyveromyces marxianus cell, the cell comprising in its genome: (i) two different nucleic acid molecules that each contain a promoter operably linked to a gene encoding a functional enzyme, and (ii) a selection nucleic acid molecule that contains a promoter operably linked to a gene encoding a selectable marker, wherein all of the nucleic acids molecules of (i) and (ii) are in tandem and the engineered cell expresses all of the proteins encoded by the genes of (i) and (ii).
    Type: Application
    Filed: May 17, 2016
    Publication date: September 1, 2016
    Inventors: Jui-Jen Chang, Wen-Hsiung Li, Chieh-Chen Huang, Hao-Yeh Lin, Ming-Che Shih